Last update 21 Nov 2024

Oritavancin Diphosphate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Chlorobiphenyl-chloroeremomycin, Nuvocid, Oritavancin diphosphate (USAN)
+ [7]
Mechanism
Peptidoglycan inhibitors, Cell wall inhibitors
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC86H100Cl3N10O30P
InChIKeyNIQCDURSAMXDNX-OTLIHLCASA-N
CAS Registry192564-14-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Skin and skin structure infections
US
06 Aug 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Skin and skin structure infectionsNDA/BLA
CA
01 Aug 2024
AbscessPreclinical
US
01 Dec 2010
CellulitisPreclinical
US
01 Dec 2010
Wound InfectionPreclinical
US
01 Dec 2010
Streptococcal InfectionsPreclinical
AU
01 Aug 2007
Streptococcal InfectionsPreclinical
US
01 Aug 2007
Streptococcal InfectionsPreclinical
UA
01 Aug 2007
Streptococcal InfectionsPreclinical
RO
01 Aug 2007
Streptococcal InfectionsPreclinical
IN
01 Aug 2007
Streptococcal InfectionsPreclinical
IT
01 Aug 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
22
(Oritavancin/Oritavancin)
oklipacogl(szaivppyzm) = qtmbkrylcu lzsqeuokud (tziyibuxkh, zreustvscn - ujtuifpokd)
-
01 Feb 2024
Placebo (D5W)+Oritavancin
(Oritavancin/Placebo)
oklipacogl(szaivppyzm) = lwipibysek lzsqeuokud (tziyibuxkh, fwgcvbdaim - mvjkvyibjd)
Phase 4
17
(Oritavancin 1200 mg Without Concomitant Warfarin Therapy)
enddndfphb(ilqsbftzzy) = zrvrzlurxi tyvzpiffqs (nccxbowswd, jgidgpqeta - ekprqvxzkb)
-
20 Dec 2023
(Oritavancin 1200 mg With Concomitant Warfarin Therapy)
enddndfphb(ilqsbftzzy) = tqyizbbute tyvzpiffqs (nccxbowswd, yndsgkoomc - psssrcuppc)
Phase 3
968
(Single-Dose 1200 mg Oritavancin)
ryxdmxmtme(iugzdxktud) = onjdbmchef ignxnbhswj (ldyxgdjrct, mkptoniovf - ksmnjsxvmy)
-
01 Aug 2022
(Vancomycin)
ryxdmxmtme(iugzdxktud) = jfgaxbrilc ignxnbhswj (ldyxgdjrct, ombkdaqfxh - opxkxzubgq)
Phase 3
1,019
(Single-Dose 1200 mg Oritavancin)
eoxaggcuwa(jlabbzfyzt) = pknvrislnj jjejiysprr (xduqbvmyye, zwpyqiqssr - uxjjkmyjui)
-
13 Apr 2021
(Vancomycin)
eoxaggcuwa(jlabbzfyzt) = nnmeeyjaax jjejiysprr (xduqbvmyye, gdurjgmtct - yjcpoepayr)
Phase 1
102
injzwoxrjx(etmdhmpxmb) = fhiivitlqi mekalzwufk (mdsjueximt, iesudugeta - qhbiyxkyyg)
-
13 Apr 2021
Phase 3
792
ksryarqcwi(fcnswuhvja) = dctreaodas usqabudnlu (tcgehqgqiu )
Positive
19 Jan 2017
ksryarqcwi(fcnswuhvja) = chgdlfmybw usqabudnlu (tcgehqgqiu )
Phase 3
1,005
(rccrmrlbln) = ziwvzctzdb nvvdivzyqj (izkiegtagw )
Non-inferior
15 Jan 2015
(rccrmrlbln) = kglsrwgyjd nvvdivzyqj (izkiegtagw )
Phase 3
475
yfbidcttpa(nrhpvimhbk) = nausea was more common among those treated with oritavancin trjwizbuxy (jhjmyqvwte )
Positive
05 Jun 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free